Previous Article | Next Article 
Infection and Immunity, April 2001, p. 2636-2642, Vol. 69, No. 4
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.4.2636-2642.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
CD8+ T Cells Have an Essential Role in
Pulmonary Clearance of Nontypeable Haemophilus influenzae
following Mucosal Immunization
A. Ruth
Foxwell,1,*
Jennelle M.
Kyd,1
Guna
Karupiah,2 and
Allan
W.
Cripps1
Division of Science and Design, Gadi Research
Centre for Human and Biomedical Sciences, University of Canberra,
Australian Capital Territory,1 and
Department of Pathology, Host Defence Group, University of
Sydney, New South Wales,2 Australia
Received 2 October 2000/Returned for modification 10 November
2000/Accepted 2 January 2001
 |
ABSTRACT |
A rodent respiratory experimental model has proved useful for
investigating the immune mechanisms responsible for clearance of
bacteria from the lungs. Immunohistochemical studies in immune and
nonimmune rats have identified the cellular kinetics of response to
bacterial pulmonary infection for CD8+, CD4+,
and 
+ T cells; B cells; and the expression of major
histocompatibility complex class II (MHC-II). During the course of
bacterial clearance, there was no apparent proliferation or
extravasation of lymphocytes, nor was there increased expression of
MHC-II in nonimmune animals despite an influx of polymorphonuclear
leukocytes, whereas in immunized animals there was an early influx of
CD8+ and 
+ T cells, followed by
enhanced expression of the MHC-II marker, cellular infiltration by
polymorphonuclear leukocytes, and finally an increased number of
CD4+ T cells. Depletion of CD8+ T cells
confirmed their vital contribution in the preprimed immune response to pulmonary infection by significantly decreasing the animals' ability to clear bacteria following challenge.
 |
INTRODUCTION |
In the area of pulmonary bacterial
infection it is still unclear which cells mediate the rapid
upregulation and control of the inflammatory response which results in
the resolution of infection and the minimization of local tissue damage
(7, 19, 47). Classical innate immune responses involving
macrophages and polymorphonuclear leukocytes (PMNs) have been seen to
assist both immune and nonimmune animals in clearing infections from
the lung over time. However, the cellular influx in immune animals is
far greater and more rapid than in nonimmune controls (18,
19). This rapid cellular response in the immune animals also
corresponds to enhanced bacterial clearance and the more rapid
resolution of inflammation, thus decreasing the opportunity for
continued damage to local tissue.
Alveolar macrophages, PMNs, and 
+ T cells have all
demonstrated surveillance and phagocytic roles at mucosal surfaces
(4, 40). Major histocompatibility complex class II
(MHC-II)-restricted CD4+ T cells have been associated with
clearance of bacterial infection (14), whereas
MHC-I-restricted CD8+ T cells appear to be more involved
with the clearance of infections, producing endogenous protein products
such as in viral infections (11) or occasionally, for
intracellular bacteria such as Listeria monocytogenes, via
the MHC-I alternative pathway (37, 38).
The establishment of a mucosal immunization model looking at the
kinetics of clearance of nontypeable Haemophilus influenzae (NTHI) in both immune and nonimmune rats and mice has enabled us to
study the humoral and cellular interactions critical for enhanced
clearance of bacteria from the lungs (18, 19). Comparison of the rat and mouse models demonstrated that the kinetics of cellular
infiltration, inflammatory cytokine production, and bacterial clearance
follow similar patterns. Whereas antibody and PMNs appeared to be
important factors utilized by previously immunized animals in clearing
NTHI from the lungs during the latter phases of infection, prepriming
of the immune system to clear the bacteria from the lung is controlled
by mechanisms set in place at a very early time point post-NTHI challenge.
To further investigate early control mechanisms in pulmonary bacterial
clearance, the kinetics of recruitment of various lymphocyte subsets
(including CD4+, CD8+, and 
+
T cells) and the levels of MHC-II marker expression were investigated in immune and nonimmune rats following challenge with NTHI. The observation that CD8+ T cells were rapidly recruited to the
lung in immunized animals following bacterial challenge led the
investigators to deplete this cell type in mice. The mouse and rat
models have been found to provide a similar response to NTHI following
pulmonary challenge in both immunized and nonimmune animals. The
combined data of rapid CD8+ T-cell recruitment and enhanced
bacterial clearance in animals with their full complement of
CD8+ T cells confirmed the role of these cells as a key
cellular component in the upregulation of bacterial clearance from
immunized animals.
 |
MATERIALS AND METHODS |
Antigen.
NTHI biotype II (NTHI 289) originally isolated from
the sputum of an adult patient suffering from chronic bronchitis and
detailed previously was used in the present study (19).
Immunization and antigen challenge.
Immunization and
pulmonary challenge were performed as previously described
(19). In summary, groups of four to five
specific-pathogen-free (SPF) White Wistar male rats or BALB/c mice that
were 8 to 10 weeks old were immunized with formalin-killed whole-cell
NTHI 289 emulsified in a 1:1 ratio in incomplete Freund adjuvant
(Sigma, St. Louis, Mo.) and injected subserosally to each Peyer's
patch so that each animal received approximately 5 × 108 CFU (rats) or 1 × 107 CFU (mice) of
bacteria. On day 14 the animals received an intratracheal (i.t.) boost
of formalin-killed NTHI 289, with rats and mice receiving 50 or 20 µl
of 1010 CFU/ml, respectively. Animals were allowed to
recover, kept under SPF conditions, and challenged with live NTHI 289 21 days after the primary immunization. Challenge was done via a
tracheal cannula with a total of 5 × 108 CFU in 50 µl for rats and 2 × 106 CFU in 20 µl for mice.
This was dispersed into the lungs with small volumes of air from a
syringe. Animals were killed by an overdose of pentobarbitone sodium
administered 0.5, 1, 2, 4, 8, 12, and 24 h after lung inoculation.
Phosphate-buffered saline (PBS) was substituted for NTHI 289 in control animals.
Bacterial clearance.
Lungs lavages with PBS and
homogenization have been previously described (19).
Bacterial counts were determined from homogenate and lung lavage
following overnight incubation of serial dilutions on chocolate blood
agar (Oxoid, Hampshire, England) in 5% CO2 at 37°C.
Histology and immunocytochemistry.
Lungs from exsanguinated
rats were infused and inflated with cold 0.25% (vol/vol)
paraformaldehyde-lysine-periodate (PLP) fixative (0.2 M lysine
phosphate buffer and 0.2 M L-lysine monohydrochloride [BDH
Chemicals, Ltd., Poole, England] in 0.1 M sodium phosphate buffer [pH
7.4]) containing 0.02 M sodium-m-periodate (Sigma) and
0.25% (vol/vol) paraformaldehyde (Sigma, Poole, England). Following
excision of the lung, the lobes were placed in fresh PLP fixative for
18 h at 4°C. Following 24 h of washing at 4°C in 0.05 M sodium
phosphate buffer (pH 7.4) containing 7% (wt/vol) sucrose, the tissue
was embedded in OCT (Tissue Tek; Miles, Inc., Elkhart, Ind.) and frozen
in a mixture of acetone and dry ice. Blocks of frozen tissue were
stored at
80°C.
Sections (6 µm) were stained with mouse anti-rat CD4 (clone W3/25) at
1/25, mouse anti-rat CD8-biotin (clone MRC OX-8) at 1/10; mouse
anti-rat CD45R (clone HIS24) at 1/800, a pan-B-cell marker; mouse
anti-rat gamma/delta T-cell receptor (clone V65) at 1/5; mouse anti-rat
Ia (monomorphic)-biotin (clone MRC OX-6) at 1/15; or mouse anti-rat
macrophages (clone ED2) at 1/200. All were obtained from Serotec
(Kidlington, Oxford, United Kingdom). Goat anti-mouse immunoglobulin G
(IgG biotinylated; Amersham, Little Chalfont, Buckinghamshire, United
Kingdom) was used as a secondary antibody for gamma/delta and
CD4+ T-cell staining and diluted 1/400 in a 1:10 dilution
of normal rat serum in stock Tris buffer (STB; 49.5 mM Tris, 13.7 mM
NaCl, 0.3 mM KCl, 1 mM phosphate buffer [Amresco, Solon, Ohio]; pH
7.6) to reduce nonspecific background staining.
Following washing of slides in Tris-buffered saline (TBS; 0.08%
[vol/vol] NaCl, 10% [wt/vol] STB) to remove the OCT, the tissue was blocked with 10% normal goat serum (Sigma) for 5 min before applying the primary antibody for 1 h at 37°C. Washing of the slides in TBS for 3 min preceded dehydration through a series of graded
alcohols and a 3-min immersion in 3% (vol/vol)
H2O2 in methanol to remove endogenous
peroxidase, before rehydration through the graded alcohols and washing
for 3 min in TBS. A biotinylated secondary antibody was then applied
(this step was not required if the primary antibody was already
biotinylated) for 30 min at room temperature before washing the mixture
for 3 min in TBS. Slides were incubated with Vectastain Elite ABC
reagent (Vector, Burlingame, Calif.) for 30 min, washed in TBS for 5 min, and developed for 5 min in DAB-imidazole (0.05%
3,3'-diaminobenzadine tetrahydrochloride [Sigma] in
dinitroaminoformamide-0.085 M Na2HPO4-0.085 M
NaH2PO4-10 mM imidazole-0.03% [vol/vol]
H2O2). The reaction was stopped by immersion in
water for 5 min. The slides were counterstained in hematoxylin,
dehydrated through graded alcohols and xylene, and mounted under glass
using DPX mountant.
Semiquantitative analysis of positive cells was achieved by assessing
25 fields of four sections from two NTHI-challenged immune and
nonimmune rats at each time point against the nonimmune PBS-challenged
animals. Estimation of cell numbers was achieved by counting positively
stained cells per field (magnified at ×40) in the infected areas of
the tissue.
In vivo CD8+ T-cell depletion.
CD8+
T-cell depletion of mice was achieved according to well-established
protocols of i.p. injection of 1 mg of anti-CD8 (clone 2.43.1, rat
IgG2b; American Type Culture Collection) 24 h prior to challenge.
The use of clone 2.43.1 to deplete mice of CD8+ T cells
prior to challenge was previously assessed by flow cytometry analysis
of splenic leukocytes. The treatment was found to be very effective,
with <1% CD8+ T lymphocytes remaining following treatment
(27). Control animals were treated with purified rat IgG
(Calbiochem, La Jolla, Calif.).
Statistical analysis.
Clearance data have been expressed as
the means ± the standard errors of the mean. Statistical
significance has been tested for by one-way analysis of variance
(ANOVA; Macintosh Systat).
 |
RESULTS |
Recruitment of CD8+ T cells is enhanced by mucosal
immunization.
The number of CD8+ T cells found in
normal rat lung was assessed by immunohistochemical staining of
PBS-challenged rats. A proportion of the cells in lymphoid aggregates
were found to be CD8+, and between one and two
CD8+ T cells were found per alveolar sac throughout the
lung (Fig. 1). Nonimmune rats challenged
with NTHI neither increased nor decreased the number of
CD8+ T cells in the lung postchallenge; however, animals
previously immunized with NTHI showed marked extravasation of
CD8+ T cells from blood vessels into the lung tissue. This
extravasation was seen as early as 30 min postchallenge with NTHI and
increased markedly over the following 24 h (Fig.
2, Table 1).

View larger version (138K):
[in this window]
[in a new window]
|
FIG. 1.
Lungs of PBS-challenged rats showing two to four
CD4+ T cells per alveoli (a) and one to two
CD8+ T cells per alveoli (b). Magnification, ×400.
|
|

View larger version (78K):
[in this window]
[in a new window]
|
FIG. 2.
CD8+ T cells present in the rat lung
following pulmonary challenge with NTHI. Nonimmune animals demonstrated
no increase in CD8+ T cells at 1 h (a), 8 h (b),
or 24 h (c). Immune animals showed marked increase in
CD8+ T cells at 1 h (d), 8 h (e), and 24 h
(f). Magnification, ×400.
|
|
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Cell types and surface markers identified in pulmonary
tissue at increasing time points postchallenge with
NTHIa
|
|

+ T-cell recruitment is transiently enhanced
following mucosal immunization.
Very few 
+ T
cells were detected in the lung tissue of nonimmune animals challenged
with NTHI. Extravasation of 
+ T cells from blood
vessels occurred at 30 min and 1 h following challenge with NTHI in
immunized animals (Fig. 3, Table 1). This accumulation of 
+ T cells was temporary, and by
24 h postchallenge very few positive cells were sporadically
detected near the larger bronchi.

View larger version (132K):
[in this window]
[in a new window]
|
FIG. 3.
 + T cells present in the rat lung
1 h following pulmonary challenge with NTHI. Nonimmune animals
demonstrated no  + T cells around the pulmonary blood
vessels (a), while immune animals showed accumulations of
 + T cells around the pulmonary blood vessels (b).
Magnification, ×400.
|
|
Recruitment of CD4+ T cells is enhanced in late-stage
clearance following mucosal immunization.
As with the normal
distribution of CD8+ T cells in PBS-challenged rats,
CD4+ T cells were scattered throughout the lung tissue,
with between two and four cells per alveolar sac, and occasional
aggregation occurred around the medium to large blood vessels (Fig. 1).
There was no change in the number of CD4+ T cells present
in the lung tissue in nonimmune rats following challenge with NTHI
(Fig. 4, Table 1). Previously immunized
animals showed no initial influx of CD4+ T cells, as was
noted with the CD8+ T cells; however, by 8 h after
challenge with NTHI a slight increase in CD4+ T cells was
detected (Fig. 4, Table 1). This influx continued over time, and a
moderate extravasation of CD4+ T cells from blood vessels
into lung tissue was observed by 24 h post-bacterial challenge.

View larger version (81K):
[in this window]
[in a new window]
|
FIG. 4.
CD4+ T cells present in the rat lung
following pulmonary challenge with NTHI. Nonimmune animals demonstrated
no increase in CD4+ T cells at 1 h (a) (magnification,
×400), 8 h (b) (magnification, ×400), or 24 h (c)
(magnification, ×200). Immune animals showed no increase in
CD4+ T cells at 1 h (d) (magnification, ×400);
however, a slight increase in CD4+ T cells was noted by
8 h (e) (magnification, ×400), and a marked infiltration of
CD4+ T cells was seen surrounding blood vessels by 24 h (f) (magnification, ×100).
|
|
MHC-II expression increases in the mid to late stages in mucosally
immunized animals in response to pulmonary bacterial challenge.
In
order to investigate the possible upregulation of bacterial antigen
presentation following exposure to NTHI, the kinetics of MHC-II
expression were investigated. Normal levels of MHC-II were assessed in
PBS-challenged animals, and MHC-II was found to be expressed on
approximately two to four cells per alveolar sac. In nonimmune animals
challenged with NTHI neither the level of expression nor the number of
cells expressing the MHC-II marker increased nor decreased with time postchallenge.
Rats previously immunized with NTHI showed a level of MHC-II expression
in the lung similar to that of the nonimmune animals at 30 min
postchallenge with NTHI (Table 1); however, as time increased the
number of cells expressing the MHC-II marker increased until 24 h
postchallenge. The levels of MHC-II expression appeared to increase
most near the blood vessels, with some extravasation of positive cells.
The majority of cells staining positive for the MHC-II marker in the
lung tissue also stained positive for the B-cell marker. Very few cells
were dendriform in shape.
CD8+ T-cell depletion reduces pulmonary bacterial
clearance in mucosally immunized animals.
Previous experiments
have demonstrated that mucosal immunization significantly enhances the
ability of rats and mice to clear NTHI from the lungs compared with the
nonimmune animals (18, 19). The immunohistochemical
studies presented here indicate a rapid upregulation of
CD8+ T cells in mucosally immunized animals challenged with
NTHI (Fig. 2, Table 1). To further confirm the significance of this
cell type in bacterial clearance following immunization, mice depleted of CD8+ were immunized and challenged with NTHI. Mice were
used in preference to rats due to the well-established depletion
protocols for CD8+ T-cell depletion in mice
(27). It had previously been established that the rat and
mouse models followed similar patterns in relation to bacterial
clearance following pulmonary challenge with NTHI (data not included).
While the depletion of CD8+ T cells from nonimmune animals
did not affect their ability to clear bacteria from the lung, the
depletion of CD8+ T cells from mucosally immunized mice
significantly inhibited pulmonary clearance of bacteria compared to
wild-type controls (Fig. 5, P
<0.05).

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 5.
Bacteria recovered from lung in wild-type and
CD8-depleted nonimmune and immune mice 4 h after challenge with
NTHI (*, P < 0.05). Values represent the mean ± standard error of the mean for four mice. Statistical analysis was
done by using ANOVA (Macintosh Systat).
|
|
 |
DISCUSSION |
Clearance of bacteria from the lungs has been found to be a
complex interaction of events. The experimental model used in this
study focuses on the clearance of bacteria from the lung and compares
immunized to nonimmune animals. The model has been well established for
the study of immune mechanisms of bacterial clearance from the lung,
and kinetic studies have demonstrated marked differences in cellular
infiltration into the lung tissues of immunized and nonimmunized
animals after challenge with NTHI (19, 20). During the
course of bacterial clearance, there was no apparent proliferation nor
extravasation of lymphocytes, nor was there increased expression of
MHC-II in nonimmune animals, whereas in immunized animals there was an
early influx of CD8+ and 
+ T cells,
followed by enhanced expression of the MHC-II marker, cellular
infiltration by PMNs (19), and finally an increased number
of CD4+ T cells. The depletion of CD8+ T cells
confirmed their vital contribution in the preprimed immune response
to pulmonary infection by decreasing the animals' ability to clear
bacteria following challenge. The expression of MHC-I would be of
interest to determine the upregulation and use of this pathway for
antigen presentation.
This study of NTHI infection in the rat lung has demonstrated the
importance of CD8+ T cells in protection from bacterial
infection in immune animals. CD8+ T cells have classically
been restricted by the MHC-I pathway and, as such, thought to be
primarily involved with providing protection against organisms
producing intracellular peptides, such as those produced from viral
infections (12, 46). Nevertheless, recent work has pointed
to the ability of CD8+ T cells to be activated through
MHC-I type presentation of peptides processed from exogenous protein
sources (31, 37, 43). Both macrophages (37,
43) and bacterially stimulated intestinal epithelial cells
(1, 2) have been shown to act as antigen-presenting cells
via the MHC-I pathway. The ability of NTHI to enter respiratory tract
epithelial cells has been demonstrated both in adenoidal tissue in vivo
(17) and in lung epithelial cells in vitro
(44) and could conceivably result in MHC-I presentation to
CD8+ T cells at both the primary immunization site in the
gut and the effector site in the respiratory tract. This bacterial
stimulation of the epithelial cells could also result in the release of
chemokines such as interleukin-8, which results in the attraction
of PMNs (15, 16), and macrophage inflammatory protein 1
(MIP-1
), which is selectively chemotactic for CD8+
T cells rather than CD4+ T cells (25).
The major roles attributed to CD8+ T cells are those of the
suppressor role, as seen in the intestinal lining (5), and
the cytolytic role, as seen when acting on macrophages infected by L. monocytogenes (23). CD8+ T-cell
control is also apparent in the downregulation of the 
+ T-cell response, as demonstrated in
2-microglobulin gene-deficient mice challenged with
Mycobacterium bovis (35), which results in the
overproliferation of 
+ T cells. Chemokines, such as
MIP-1
and lymphotactin, produced by 
+ T cells and
CD8+ T cells, have been found to attract CD8+ T
cells to sites of infection (3, 9). This feedback
mechanism of CD8+ T-cell attraction, due partially to the
production of chemokines from 
+ T cells
(3), would further strengthen the evidence for the ability
to preprime 
+ T cells by immunization, since no
CD8+ T cells accumulated in nonimmunized animals.

+ T cells may act either to protect the host's
pulmonary tissue from the pathogenic insult by targeting the
inflammatory response to epithelial necrosis (29) or to
help achieve the fine balance required between the induction of
tolerance (28), regulation of allergic response (32,
41), and stimulation of an appropriate inflammatory response to
infection (4). Stimulation and initial influx of the

+ T cells, as seen in immunized animals, may be due
either to small, nonpeptidic, phosphorylated compounds
(24) or to alkylamines derived from the bacteria
(6).
The increased numbers of 
+ T cells found in the
immunized animals, combined with the demonstration of proliferation in
response to specific allergens (42), provides evidence for
the ability to prime 
+ T cells to respond to specific
antigens. This priming may be due to either a direct response, as seen
with 
+ T cells following immunization
(30), or an indirect stimulation of 
+ T
cells via MHC-II-restricted CD4+ T cells, as seen with the
expansion of 
+ T cells in the spleen of mice infected
with Leishmania major (39). Nevertheless, upon
viewing the time frame of cellular response in the current model, we
found that 
+ T cells increased and decreased in
number well before CD4+ T cells showed any signs of
expansion. It is very plausible, however, that CD4+ T cells
were actively secreting stimulatory cytokines well before proliferation. Antigen specificity and 
+ T-cell
depletion studies will help define their role in pulmonary bacterial clearance.
With the lack of gamma interferon found in the bronchoalveolar lavage
fluid of rats (20) and the evidence that

+ T cells can contain intracellular stores of
interleukin-4 (41), the early presence of

+ T cells at the site of infection may help mediate a
Th2 type response postimmunization. This would be beneficial in
optimizing the levels of IgA at the mucosal surface (34).
Upregulation of MHC-II was observed by 2 h postchallenge with NTHI
in immunized animals. The levels of MHC-II expression continued to rise
until live bacteria had been eliminated from the lung. The precise role
for the upregulation of MHC-II expression in this model is ambiguous.
Previous work on respiratory tract infection with Moraxella
catarrhalis had demonstrated the importance of dendritic cell
infiltration along the length of the trachea following bacterial
challenge (33). However, the majority of cells showing MHC-II expression in the bronchi and alveolar sacs of immunized animals
following pulmonary challenge with NTHI also stained positively for
B-cell markers. While there is evidence that dendritic cells are
extremely important in their surveillance role in the respiratory tract
(22) and while in vitro they are more efficient at antigen presentation to T cells than macrophages, their ability to uptake and
present antigen without macrophage help is minimal (21, 36). The relationship between dendritic cells and macrophages is
complex, with small numbers of lung interstitial macrophages enhancing
the ability of dendritic cells to act as antigen-presenting cells,
whereas large numbers of macrophages have an inhibitory effect on the
process (21). For this reason, the MHC-II recruitment observed in this model may be a demonstration that it is more effective
for the respiratory tract to recruit different groups of
antigen-presenting cells to separate but interconnecting locations in
order to maximize their antigen-processing potential.
The kinetics of change in the CD4+ T-cell numbers were very
different, with no proliferation of CD4+ T cells at the
early time points postchallenge with NTHI. It is thought that these T
cells play an important role in enhancing the clearance of bacteria in
immune compared to nonimmune rats through both innate (8)
and acquired (13) mechanisms. In addition to the
traditional antigen-presenting pathways for CD4+ T-cell
activation, bacterial entry into intestinal epithelial cells can result
in the presentation of antigen to CD4+ T cells via MHC-II
(26). Furthermore, it has been shown that the transfer of
purified preprimed CD4+ T cells or purified
preprimed T cells from mucosally immunized rats to naive
recipients, followed by either challenge with homologous strains of
Pseudomonas aeruginosa (14) or NTHI
(45) resulted in enhanced bacterial clearance compared to
control animals receiving T cells from nonimmunized animals.
Interestingly, T-cell transfer experiments from immunized to naive mice
have also been shown to enhance innate mechanisms such as the
recruitment and activation of macrophages and polymorphs to the site of
challenge in experiments involving L. monocytogenes
(10). CD4+ T-cell depletion studies will help
us to clarify their role in respiratory immunity to NTHI.
Kinetic studies on the influx of cells to the lungs of animals
challenged with NTHI have shown an enhancement of cell numbers in
immune compared with nonimmune animals over time. The accumulation of

+ T cells observed in immune but not in nonimmune
rats demonstrates the possibility that mucosal immunization has the
ability to preprime these cells to respond to specific antigen.
Additionally, the massive and rapid extravasation of
CD8+ T cells to the lung post-bacterial challenge in
immunized animals, combined with inhibition of bacterial clearance
following CD8+ T-cell depletion, demonstrates the
importance of this cell type in the clearance of NTHI.
 |
ACKNOWLEDGMENTS |
We thank Rosario Rosaria and Capital Pathology for advice and
help in the immunohistological techniques.
This work was supported by National Health and Medical Research Grant
951089 and a collaborative Research Scholarship from the John Curtin
School of Medical Research, Australian National University, Canberra, Australia.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Division of
Science and Design, University of Canberra, Canberra, ACT 2601, Australia. Phone: 61-6201-2089. Fax: 61-6201-2461. E-mail:
foxwell{at}scides.canberra.edu.au.
Editor:
D. L. Burns
 |
REFERENCES |
| 1.
|
Blumberg, R. S.
1998.
Current concepts in mucosal immunity II. One size fits all: nonclassical MHC molecules fulfill multiple roles in epithelial cell function.
Am. J. Physiol.
2(Pt. 1):G227-G231.
|
| 2.
|
Blumberg, R. S.,
N. Simister,
A. D. Christ,
E. J. Israel,
S. P. Colgan, and S. P. Balk.
1996.
MHC-like molecules on mucosal epithelial cells, p. 85-99.
In
M. F. Kagnoff, and H. Kiyono (ed.), Essentials of mucosal immunology. Academic Press, Inc., San Diego, Calif.
|
| 3.
|
Boismenu, R.,
L. Feng,
Y. Y. Xia,
J. C. C. Chang, and W. L. Havran.
1996.
Chemokine expression by intraepithelial  T cells: implications for the recruitment of inflammatory cells to damaged epithelia.
J. Immunol.
157:985-992[Abstract].
|
| 4.
|
Boismenu, R., and W. L. Havran.
1998.
 T cells in host defense and epithelial cell biology.
Clin. Immunol. Immunopathol.
86:121-133[CrossRef][Medline].
|
| 5.
|
Brandtzaeg, P.,
T. S. Halstensen,
K. Kett,
P. Krajci,
D. Kvale,
T. O. Rognum,
H. Scott, and L. M. Sollid.
1989.
Immunobiology and immunopathology of human gut mucosa: humoral immunity and intraepithelial lymphocytes.
Gastroenterology
97:1562-1584[Medline].
|
| 6.
|
Bukowski, J. F.,
C. T. Morita, and M. B. Brenner.
1999.
Human gamma delta T cells recognize alkylamines derived from microbes, edible plants, and tea: implications for innate immunity.
Immunity
11:57-65[CrossRef][Medline].
|
| 7.
|
Buret, A.,
M. L. Dunkley,
G. Pang,
R. L. Clancy, and A. W. Cripps.
1994.
Pulmonary immunity to Pseudomonas aeruginosa in intestinally immunized rats: roles of alveolar macrophages, tumor necrosis factor alpha, and interleukin-1 .
Infect. Immun.
62:5335-5343[Abstract/Free Full Text].
|
| 8.
|
Campbell, P. A.
1990.
The neutrophil, a professional killer of bacteria, may be controlled by T cells.
Clin. Exp. Immunol.
79:141-143[Medline].
|
| 9.
|
Cocchi, F.,
A. L. DeVico,
A. Garzino-Demo,
S. K. Arya,
R. C. Gallo, and P. Lusso.
1995.
Identification of rantes, MIP-1 , and MIP-1 as the major HIV-suppressive factors produced by CD8+ T cells.
Science
270:1811-1815[Abstract/Free Full Text].
|
| 10.
|
Czuprynski, C. J.,
P. M. Henson, and P. A. Campbell.
1985.
Enhanced accumulation of inflammatory neutrophils and macrophages mediated by transfer of T cells from mice immunized with Listeria monocytogenes.
J. Immunol.
134:3449-3454[Abstract].
|
| 11.
|
Doherty, P. C.
1997.
Cell mediated immunity in virus infections.
Scand. J. Immunol.
46:528-540[CrossRef].
|
| 12.
|
Doherty, P. C.,
D. J. Topham,
R. A. Tripp,
R. D. Cardin,
J. W. Brooks, and P. G. Stevenson.
1997.
Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections.
Immunol. Rev.
159:105-117[CrossRef][Medline].
|
| 13.
|
Dunkley, M.,
R. Pabst, and A. Cripps.
1995.
An important role for intestinally-derived T cells in respiratory defence.
Immunol. Today
16:231-236[CrossRef][Medline].
|
| 14.
|
Dunkley, M. L.,
R. L. Clancy, and A. W. Cripps.
1994.
A role for CD4+ T cells from orally immunized rats in enhanced clearance of Pseudomonas aeruginosa from the lung.
Immunology
83:362-369[Medline].
|
| 15.
|
Eckmann, L.,
H. C. Jung,
C. Schürer-Maly,
A. Panja,
E. Morzycka-Wroblewska, and M. F. Kagnoff.
1993.
Differential cytokine expression by human intestinal epithelial cell: regulation expression of interleukin 8.
Gastroenterology
105:1689-1697[Medline].
|
| 16.
|
Eckmann, L.,
M. F. Kagnoff, and J. Fierer.
1993.
Epithelial cells secrete the chemokine interleukin-8 in response to bacterial entry.
Infect. Immun.
61:4569-4574[Abstract/Free Full Text].
|
| 17.
|
Forsgren, J.,
A. Samuelson,
A. Ahlin,
J. Jonasson,
B. Rynnel-Dagoo, and A. Lindberg.
1994.
Haemophilus influenzae resides and multiplies intracellularly in human adenoid tissue as demonstrated by in situ hybridization and bacterial viability assay.
Infect. Immun.
62:673-679[Abstract/Free Full Text].
|
| 18.
|
Foxwell, A. R.
1998.
Mechanisms of immunity to nontypeable Haemophilus influenzae in the lung. Ph.D. thesis.
University of Canberra, Canberra, Australia.
|
| 19.
|
Foxwell, A. R.,
J. M. Kyd, and A. W. Cripps.
1998.
Characteristics of the immunological response in the clearance of nontypeable Haemophilus influenzae from the lung.
Immunol. Cell Biol.
76:323-331[CrossRef][Medline].
|
| 20.
|
Foxwell, A. R.,
J. M. Kyd, and A. W. Cripps.
1998.
Kinetics of inflammatory cytokines in the clearance of nontypeable Haemophilus influenzae from the lung.
Immunol. Cell Biol.
76:556-559[CrossRef][Medline].
|
| 21.
|
Gong, J. L.,
K. M. McCarthy,
R. A. Rogers, and E. E. Schneeberger.
1994.
Interstitial lung macrophages interact with dendritic cells to present antigenic peptides derived from particulate antigens to T cells.
Immunology
81:343-351[Medline].
|
| 22.
|
Holt, P. G.,
S. Haining,
D. J. Nelson, and J. D. Sedgwick.
1994.
Origin and steady-state turnover of class II MHC-bearing dendritic cells in the epithelium of the conducting airway.
J. Immunol.
153:153-161[Abstract].
|
| 23.
|
Jiang, X.,
S. H. Gregory, and E. J. Wing.
1997.
Immune CD8+ T lymphocytes lyse Listeria monocytogenes-infected hepatocytes by a classical MHC class I-restricted mechanism.
J. Immunol.
158:287-293[Abstract].
|
| 24.
|
Julia, M. R.,
P. Serra,
N. Matamoros,
S. Raga, and P. Matinez.
1998.
Small cytoplasmic antigens from Pseudomonas aeruginosa stimulate gamma/delta T lymphocytes.
Scand. J. Immunol.
48:672-678[CrossRef][Medline].
|
| 25.
|
Jung, H. C.,
L. Eckmann,
S.-K. Yang,
A. Panja,
J. Fierer,
E. Morzycka-Wroblewska, and M. F. Kagnoff.
1995.
A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion.
J. Clin. Investig.
95:55-65.
|
| 26.
|
Kaiserlian, D.,
K. Vidal, and J.-P. Revillard.
1989.
Murine enterocytes can present soluble antigens to specific class II-restricted CD4+ T cells.
Eur. J. Immunol.
19:1513-1516[Medline].
|
| 27.
|
Karupiah, G.,
R. M. L. Buller,
N. van Rooijen,
C. J. Duarte, and J. Chen.
1996.
Different roles for CD4+ and CD8+ T lymphocytes and macrophage subsets in the control of a generalized virus infection.
J. Virol.
70:8301-8309[Abstract].
|
| 28.
|
Ke, Y.,
J. P. Lake,
H. K. Ziegler, and J. A. Kapp.
1997.
 T lymphocytes regulate the induction and maintenance of oral tolerance.
J. Immunol.
158:3610-3618[Abstract].
|
| 29.
|
King, D. P.,
D. M. Hyde,
K. A. Jackson,
D. M. Novosad,
T. N. Ellis,
L. Putney,
M. Y. Stovall,
L. S. Van Winkle,
B. L. Beaman, and D. A. Ferrick.
1999.
Cutting edge: protective response to pulmoary injury requires gamma delta T lymphocytes.
J. Immunol.
162:5033-5036[Abstract/Free Full Text].
|
| 30.
|
Kyd, J. M.,
M. L. Dunkley, and A. W. Cripps.
1995.
Enhanced respiratory clearance of nontypeable Haemophilus influenzae following mucosal immunization with P6 in a rat model.
Infect. Immun.
63:2931-2940[Abstract].
|
| 31.
|
Matinez-Kinader, B.,
G. B. Lipford,
H. Wagner, and K. Heeg.
1995.
Sensitization of MHC class I-restricted T cells to exogenous proteins: evidence for an alternative class I-restricted antigen presentation pathway.
Immunology
86:287-295[Medline].
|
| 32.
|
McMenamin, C.,
C. Pimm,
M. McKersey, and P. G. Holt.
1994.
Regulation of IgE responses to inhaled antigen in mice by antigen-specific  T cells.
Science
265:1869-1871[Abstract/Free Full Text].
|
| 33.
|
McWilliam, A. S.,
D. Nelson,
J. A. Thomas, and P. G. Holt.
1994.
Rapid dendritic cell recruitment is a hallmark of the acute inflammatory response at mucosal surfaces.
J. Exp. Med.
179:1331-1336[Abstract/Free Full Text].
|
| 34.
|
Mosmann, T. R., and S. Sad.
1996.
The expanding universe of T-cell subsets: Th1, Th2 and more.
Immunol. Today
17:138-146[CrossRef][Medline].
|
| 35.
|
Muller, D.,
P. Pakpreo,
J. Filla,
K. Pederson,
F. Cigel, and V. Malkovska.
1995.
Increased gamma-delta T-lymphocyte response to Mycobacterium bovis BCG in major histocompatibility complex class I-deficient mice.
Infect. Immun.
63:2361-2366[Abstract].
|
| 36.
|
Nair, S.,
A. M. J. Buiting,
R. J. D. Rouse,
N. Van Rooijen,
L. Huang, and B. T. Rouse.
1995.
Role of macrophages and dendritic cells in primary cytotoxic T lymphocyte responses.
Int. Immunol.
7:679-688[Abstract/Free Full Text].
|
| 37.
|
Pfeifer, J. D.,
M. J. Wick,
R. L. Roberts,
K. Findlay,
S. J. Normark, and C. V. Harding.
1993.
Phagocytic processing of bacterial antigens for class I MHC presentation to T cells.
Science
361:359-362.
|
| 38.
|
Rock, K. L.
1996.
A new foreign policy: MHC class I molecules monitor the outside world.
Immunol. Today
17:131-137[CrossRef][Medline].
|
| 39.
|
Rosat, J.-P.,
F. Conceiçao-Silva,
G. A. Waanders,
F. Beermann,
A. Wilson,
M. J. Owen,
A. C. Hayday,
S. Huang,
M. Aguet,
H. R. MacDonald, and J. A. Louis.
1995.
Expansion of  + T cells in BALB/c mice infected with Leishmania major is dependent upon Th-2 type CD4+ T cells.
Infect. Immun.
63:3000-3004[Abstract].
|
| 40.
|
Sibille, Y., and H. Y. Reynolds.
1990.
Macrophages and polymorphonuclear neutrophils in lung defense and injury.
Am. Rev. Respir. Dis.
141:471-501[Medline].
|
| 41.
|
Spinozzi, F.,
E. Agea,
O. Bistoni,
N. Forenza, and A. Bertotto.
1998.
 T cells, allergen recognition and airway inflammation.
Immunol. Today
19:22-26[CrossRef][Medline].
|
| 42.
|
Spinozzi, F.,
E. Agea,
O. Bistoni,
N. Forenza,
A. Monaco,
C. Riccardi,
F. Grignani, and A. Bertotto.
1996.
Increased allergen-specific, steroid-sensitive  T cells in bronchoalveolar lavage fluid from patients with asthma.
Ann. Intern. Med.
124:223-227[Abstract/Free Full Text].
|
| 43.
|
Suto, R., and P. K. Srivastava.
1995.
A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides.
Science
269:1585-1588[Abstract/Free Full Text].
|
| 44.
|
van Schilfgaarde, M.,
L. van Alphen,
P. Eijk,
V. Everts, and J. Dankert.
1995.
Paracytosis of Haemophilus influenzae through cell layers of NCI-H292 lung epithelial cells.
Infect. Immun.
63:4729-4737[Abstract].
|
| 45.
|
Wallace, F. J.,
A. W. Cripps,
R. L. Clancy,
A. J. Husband, and C. S. Witt.
1991.
A role for intestinal T lymphocytes in bronchus mucosal immunity.
Immunology
74:68-73[Medline].
|
| 46.
|
Welsh, R. M.,
M.-Y. Lin,
B. L. Lohman,
S. M. Varga,
C. C. Zarozinski, and L. K. Selin.
1997.
 and  T-cell networks and their roles in natural resistance to viral infections.
Immunol. Rev.
159:79-93[CrossRef][Medline].
|
| 47.
|
Wilson, N. R.,
M. L. Dunkley,
A. Buret,
B. Young, and A. W. Cripps.
1995.
Histopathology of the lung following intratracheal challenge with live Pseudomonas aeruginosa in intestinally immunized rats.
Immunol. Cell Biol.
73:440-445[Medline].
|
Infection and Immunity, April 2001, p. 2636-2642, Vol. 69, No. 4
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.4.2636-2642.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Abe, Y., Murphy, T. F., Sethi, S., Faden, H. S., Dmochowski, J., Harabuchi, Y., Thanavala, Y. M.
(2002). Lymphocyte Proliferative Response to P6 of Haemophilus influenzae Is Associated with Relative Protection from Exacerbations of Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med.
165: 967-971
[Abstract]
[Full Text]